These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38904017)

  • 1. CD8 T cells induce the peritubular capillary rarefaction during AKI to CKD transition.
    Jiang W; Tang TT; Zhang YL; Li ZL; Wen Y; Yang Q; Fu YQ; Song J; Wu QL; Wu M; Wang B; Liu BC; Lv LL
    Int J Biol Sci; 2024; 20(8):2980-2993. PubMed ID: 38904017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease.
    Wang C; Zhang Y; Shen A; Tang T; Li N; Xu C; Liu B; Lv L
    Front Immunol; 2024; 15():1385696. PubMed ID: 38770013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
    de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
    Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
    Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury.
    Lan S; Yang B; Migneault F; Turgeon J; Bourgault M; Dieudé M; Cardinal H; Hickey MJ; Patey N; Hébert MJ
    Am J Physiol Renal Physiol; 2021 Sep; 321(3):F335-F351. PubMed ID: 34338031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
    Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
    EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
    Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
    Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISG15 accelerates acute kidney injury and the subsequent AKI-to-CKD transition by promoting TGFβR1 ISGylation.
    Cui N; Liu C; Tang X; Song L; Xiao Z; Wang C; Wu Y; Zhou Y; Peng C; Liu Y; Zheng L; Liu X; Huang K; Chen H
    Theranostics; 2024; 14(11):4536-4553. PubMed ID: 39113797
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
    Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
    Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Novel ECM Remodeling Macrophage Subset in AKI to CKD Transition by Integrative Spatial and Single-Cell Analysis.
    Zhang YL; Tang TT; Wang B; Wen Y; Feng Y; Yin Q; Jiang W; Zhang Y; Li ZL; Wu M; Wu QL; Song J; Crowley SD; Lan HY; Lv LL; Liu BC
    Adv Sci (Weinh); 2024 Oct; 11(38):e2309752. PubMed ID: 39119903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects of AKI to CKD models on inflammation and fibrosis.
    Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.
    Mehrotra P; Collett JA; McKinney SD; Stevens J; Ivancic CM; Basile DP
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F385-F397. PubMed ID: 27852609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
    Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
    Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.
    Wei J; Zhang J; Wang L; Jiang S; Fu L; Buggs J; Liu R
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F286-F295. PubMed ID: 31116604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
    Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7.
    Li L; Lee J; Cho A; Kim JH; Ju W; An JN; Park JH; Zhu SM; Lee J; Yu SS; Lim CS; Kim DK; Kim YS; Yang SH; Lee JP
    Clin Sci (Lond); 2021 Jun; 135(11):1427-1444. PubMed ID: 34061176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice.
    Kramann R; Tanaka M; Humphreys BD
    J Am Soc Nephrol; 2014 Sep; 25(9):1924-31. PubMed ID: 24652794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
    Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
    Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
    Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.